Alpha 2.0
Login Register
» Authors » Alain Filion

Alain Filion

Explore the profile of Alain Filion including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 77
Followers 0
Related Specialties
Hematology
General Surgery
Oncology
Top 10 Co-Authors
Eliane Gluckman
Gerard Socie
Vanderson Rocha
Dominique Charron
Ryad Tamouza
Jerome Larghero
Marc Busson
Marie Robin
Marc Benbunan
Antoine Toubert
Published In
Blood
Nephrol Dial Transplant
Transplantation
Haematologica
Br J Haematol
Affiliations
Soon will be listed here.
Recent Articles
1.
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada
Cheung W, Samimi S, Ma K, Knight G, Kassam S, Colwell B, et al.
Clin Colorectal Cancer . 2023 Nov; 23(1):46-57.e4. PMID: 38007297
Background: ABP 215 is a biosimilar to the reference product, bevacizumab, and was one of the first biosimilars approved by Health Canada for the first-line treatment of metastatic colorectal cancer...
2.
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease
Laverdiere I, Guillemette C, Tamouza R, Loiseau P, Peffault de Latour R, Robin M, et al.
Haematologica . 2014 Nov; 100(2):275-83. PMID: 25425682
Effective immunosuppression is mandatory to prevent graft-versus-host disease and to achieve a successful clinical outcome of hematopoietic stem cell transplantation. Here we tested whether germline single nucleotide polymorphisms in 20...
3.
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation
Philibert D, Desmeules S, Filion A, Poirier M, Agharazii M
Nephrol Dial Transplant . 2007 Aug; 23(1):359-63. PMID: 17720988
Background: Haematopoietic stem cell transplantation (HSCT) has gained worldwide acceptance as a therapeutic option for many haematological and non-haematological conditions. Local experience supports that electrolyte abnormalities are quite common; however,...
4.
Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants
Larghero J, Rocha V, Porcher R, Filion A, Ternaux B, Lacassagne M, et al.
Br J Haematol . 2007 Jun; 138(1):101-9. PMID: 17555453
Allogeneic bone marrow (BM) transplant (BMT) outcomes have been correlated with the infused nucleated, CD34(+), and T- cell dose. The potential impact of natural killer (NK) BM infused cell dose...
5.
Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation
Tamouza R, Rocha V, Busson M, Fortier C, El Sherbini S, Esperou H, et al.
Transplantation . 2005 Jul; 80(1):140-4. PMID: 16003246
Despite prophylactic measures, susceptibility to severe infections in patients who had undergone bone marrow transplantation (BMT) is quite variable. To evaluate the potential role of human leukocyte antigen (HLA)-E polymorphism...
6.
Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation
Clave E, Rocha V, Talvensaari K, Busson M, Douay C, Appert M, et al.
Blood . 2004 Nov; 105(6):2608-13. PMID: 15546951
Thymic function is critical for immune reconstitution after hematopoietic stem cell transplantation (HSCT). We evaluated recipient thymic function before HSCT by quantifying T-cell receptor excision circles (TRECs) in pretransplantation peripheral...
7.
Hematopoietic progenitor cel harvest and functionality in Fanconi anemia patients
Larghero J, Marolleau J, Soulier J, Filion A, Rocha V, Benbunan M, et al.
Blood . 2002 Oct; 100(8):3051. PMID: 12382645
No abstract available.